vTv Therapeutics (VTVT) Misses Q2 EPS by 92c

vTv Therapeutics (NASDAQ: VTVT) reported Q2 EPS of ($0.92).

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• Comcast (CMCSA) Falls Following Comments at Goldman Sachs Conf, Down 4%
• Needham on Barnes & Noble Education (BNED): 'we remain buyers on the weakness'
• Texas Instruments (TXN) Reiterated at Neutral by Cantor Fitzgerald on Upside to Earnings Power